New

Epilepsy Drugs Market

2021

Epilepsy Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics); Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others) and Geography

| Report Code: TIPRE00024323 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Epilepsy Drugs Market 2028 By Treatment, Distribution Channel and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Epilepsy is a chronic central nervous system disorder (neurological disorder). It is characterized by abnormal brain activity that results in sudden and recurrent seizures or periods of unusual behavior and sensations. It affects people of all ages, and the majority of the cases have no identifiable cause. The epilepsy drugs help in the treatment of seizures (symptomatic treatment), although there is no cure for epilepsy.

MARKET SCOPE

The "Global Epilepsy Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the epilepsy drugs market with detailed market segmentation by treatment, distribution channel and geography. The report provides key statistics on the market status of the leading epilepsy drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on treatment, the global epilepsy drugs market is segmented into first generation anti-epileptics, second generation anti-epileptics and third generation anti-epileptics.
  •  Based on distribution channel, the market is segmented into hospital pharmacy, pharmacy stores and others.

MARKET DYNAMICS
Drivers:

  •  Increase in the incidences of epilepsy, neurological disorders, and birth-related injuries.
  •  The rise in the new drug approvals.
  •  Growing awareness regarding epilepsy disease.
  •  Increase in the investment for R&D activities.

Restraints:

  •  High cost of patented drugs.
  •  Low accessibility to epilepsy drugs in low and middle-income economies.
  •  Certain side effects associated with the drugs.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The epilepsy drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the epilepsy drugs market in these regions.

IMPACT OF COVID-19ON EPILEPSY DRUGS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The coronavirus outbreak caused a worldwide economic crisis. All the industrial manufacturing operations were halted due to the restrictive measures, lockdown, and business shutdown. The disruptions in the regular operation of business caused a significant impact on the epilepsy drugs market growth. The shutdown of various plants and factories affected the worldwide supply chains and negatively impacted the market's manufacturing, delivery schedules, and products sale. However, the market is expected to witness growth in demand in the future.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the epilepsy drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from epilepsy drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for epilepsy drugs in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the epilepsy drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Pfizer, Inc.
  •  Novartis AG
  •  Abbott Laboratories
  •  Sanofi S.A.
  •  UCB S.A.
  •  GlaxoSmithKline plc
  •  Sunovion Pharmaceuticals Inc.
  •  Teva Pharmaceutical Industries Ltd.
  •  Takeda Pharmaceutical
  •  Eisai Co., Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Epilepsy Drugs Market - By Treatment
1.3.2 Epilepsy Drugs Market - By Distribution Channel
1.3.3 Epilepsy Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. EPILEPSY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. EPILEPSY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. EPILEPSY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. EPILEPSY DRUGS - GLOBAL MARKET OVERVIEW
6.2. EPILEPSY DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. EPILEPSY DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. FIRST GENERATION ANTI-EPILEPTICS
7.3.1. Overview
7.3.2. First Generation Anti-epileptics Market Forecast and Analysis
7.4. SECOND GENERATION ANTI-EPILEPTICS
7.4.1. Overview
7.4.2. Second Generation Anti-epileptics Market Forecast and Analysis
7.5. THIRD GENERATION ANTI-EPILEPTICS
7.5.1. Overview
7.5.2. Third Generation Anti-epileptics Market Forecast and Analysis
8. EPILEPSY DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACY
8.3.1. Overview
8.3.2. Hospital Pharmacy Market Forecast and Analysis
8.4. PHARMACY STORES
8.4.1. Overview
8.4.2. Pharmacy Stores Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. EPILEPSY DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Epilepsy Drugs Market Overview
9.1.2 North America Epilepsy Drugs Market Forecasts and Analysis
9.1.3 North America Epilepsy Drugs Market Forecasts and Analysis - By Treatment
9.1.4 North America Epilepsy Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Epilepsy Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Epilepsy Drugs Market
9.1.5.1.1 United States Epilepsy Drugs Market by Treatment
9.1.5.1.2 United States Epilepsy Drugs Market by Distribution Channel
9.1.5.2 Canada Epilepsy Drugs Market
9.1.5.2.1 Canada Epilepsy Drugs Market by Treatment
9.1.5.2.2 Canada Epilepsy Drugs Market by Distribution Channel
9.1.5.3 Mexico Epilepsy Drugs Market
9.1.5.3.1 Mexico Epilepsy Drugs Market by Treatment
9.1.5.3.2 Mexico Epilepsy Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Epilepsy Drugs Market Overview
9.2.2 Europe Epilepsy Drugs Market Forecasts and Analysis
9.2.3 Europe Epilepsy Drugs Market Forecasts and Analysis - By Treatment
9.2.4 Europe Epilepsy Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Epilepsy Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Epilepsy Drugs Market
9.2.5.1.1 Germany Epilepsy Drugs Market by Treatment
9.2.5.1.2 Germany Epilepsy Drugs Market by Distribution Channel
9.2.5.2 France Epilepsy Drugs Market
9.2.5.2.1 France Epilepsy Drugs Market by Treatment
9.2.5.2.2 France Epilepsy Drugs Market by Distribution Channel
9.2.5.3 Italy Epilepsy Drugs Market
9.2.5.3.1 Italy Epilepsy Drugs Market by Treatment
9.2.5.3.2 Italy Epilepsy Drugs Market by Distribution Channel
9.2.5.4 Spain Epilepsy Drugs Market
9.2.5.4.1 Spain Epilepsy Drugs Market by Treatment
9.2.5.4.2 Spain Epilepsy Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Epilepsy Drugs Market
9.2.5.5.1 United Kingdom Epilepsy Drugs Market by Treatment
9.2.5.5.2 United Kingdom Epilepsy Drugs Market by Distribution Channel
9.2.5.6 Rest of Europe Epilepsy Drugs Market
9.2.5.6.1 Rest of Europe Epilepsy Drugs Market by Treatment
9.2.5.6.2 Rest of Europe Epilepsy Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Epilepsy Drugs Market Overview
9.3.2 Asia-Pacific Epilepsy Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Epilepsy Drugs Market Forecasts and Analysis - By Treatment
9.3.4 Asia-Pacific Epilepsy Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Epilepsy Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Epilepsy Drugs Market
9.3.5.1.1 Australia Epilepsy Drugs Market by Treatment
9.3.5.1.2 Australia Epilepsy Drugs Market by Distribution Channel
9.3.5.2 China Epilepsy Drugs Market
9.3.5.2.1 China Epilepsy Drugs Market by Treatment
9.3.5.2.2 China Epilepsy Drugs Market by Distribution Channel
9.3.5.3 India Epilepsy Drugs Market
9.3.5.3.1 India Epilepsy Drugs Market by Treatment
9.3.5.3.2 India Epilepsy Drugs Market by Distribution Channel
9.3.5.4 Japan Epilepsy Drugs Market
9.3.5.4.1 Japan Epilepsy Drugs Market by Treatment
9.3.5.4.2 Japan Epilepsy Drugs Market by Distribution Channel
9.3.5.5 South Korea Epilepsy Drugs Market
9.3.5.5.1 South Korea Epilepsy Drugs Market by Treatment
9.3.5.5.2 South Korea Epilepsy Drugs Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Epilepsy Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Epilepsy Drugs Market by Treatment
9.3.5.6.2 Rest of Asia-Pacific Epilepsy Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Epilepsy Drugs Market Overview
9.4.2 Middle East and Africa Epilepsy Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Epilepsy Drugs Market Forecasts and Analysis - By Treatment
9.4.4 Middle East and Africa Epilepsy Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Epilepsy Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Epilepsy Drugs Market
9.4.5.1.1 South Africa Epilepsy Drugs Market by Treatment
9.4.5.1.2 South Africa Epilepsy Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Epilepsy Drugs Market
9.4.5.2.1 Saudi Arabia Epilepsy Drugs Market by Treatment
9.4.5.2.2 Saudi Arabia Epilepsy Drugs Market by Distribution Channel
9.4.5.3 U.A.E Epilepsy Drugs Market
9.4.5.3.1 U.A.E Epilepsy Drugs Market by Treatment
9.4.5.3.2 U.A.E Epilepsy Drugs Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Epilepsy Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Epilepsy Drugs Market by Treatment
9.4.5.4.2 Rest of Middle East and Africa Epilepsy Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Epilepsy Drugs Market Overview
9.5.2 South and Central America Epilepsy Drugs Market Forecasts and Analysis
9.5.3 South and Central America Epilepsy Drugs Market Forecasts and Analysis - By Treatment
9.5.4 South and Central America Epilepsy Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Epilepsy Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Epilepsy Drugs Market
9.5.5.1.1 Brazil Epilepsy Drugs Market by Treatment
9.5.5.1.2 Brazil Epilepsy Drugs Market by Distribution Channel
9.5.5.2 Argentina Epilepsy Drugs Market
9.5.5.2.1 Argentina Epilepsy Drugs Market by Treatment
9.5.5.2.2 Argentina Epilepsy Drugs Market by Distribution Channel
9.5.5.3 Rest of South and Central America Epilepsy Drugs Market
9.5.5.3.1 Rest of South and Central America Epilepsy Drugs Market by Treatment
9.5.5.3.2 Rest of South and Central America Epilepsy Drugs Market by Distribution Channel

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. EPILEPSY DRUGS MARKET, KEY COMPANY PROFILES
11.1. PFIZER, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. NOVARTIS AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ABBOTT LABORATORIES
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI S.A.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. UCB S.A.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GLAXOSMITHKLINE PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SUNOVION PHARMACEUTICALS INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TAKEDA PHARMACEUTICAL
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. EISAI CO., LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer, Inc.
2. Novartis AG
3. Abbott Laboratories
4. Sanofi S.A.
5. UCB S.A.
6. GlaxoSmithKline plc
7. Sunovion Pharmaceuticals Inc.
8. Teva Pharmaceutical Industries Ltd.
9. Takeda Pharmaceutical
10. Eisai Co., Ltd
TIPRE00024323
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.